Hyper-IgM syndrome type 1

Jump to: navigation, search
Hyper-IgM syndrome type 1
ICD-10 D80.5
ICD-9 279.05
MeSH D053307

WikiDoc Resources for Hyper-IgM syndrome type 1

Articles

Most recent articles on Hyper-IgM syndrome type 1

Most cited articles on Hyper-IgM syndrome type 1

Review articles on Hyper-IgM syndrome type 1

Articles on Hyper-IgM syndrome type 1 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hyper-IgM syndrome type 1

Images of Hyper-IgM syndrome type 1

Photos of Hyper-IgM syndrome type 1

Podcasts & MP3s on Hyper-IgM syndrome type 1

Videos on Hyper-IgM syndrome type 1

Evidence Based Medicine

Cochrane Collaboration on Hyper-IgM syndrome type 1

Bandolier on Hyper-IgM syndrome type 1

TRIP on Hyper-IgM syndrome type 1

Clinical Trials

Ongoing Trials on Hyper-IgM syndrome type 1 at Clinical Trials.gov

Trial results on Hyper-IgM syndrome type 1

Clinical Trials on Hyper-IgM syndrome type 1 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hyper-IgM syndrome type 1

NICE Guidance on Hyper-IgM syndrome type 1

NHS PRODIGY Guidance

FDA on Hyper-IgM syndrome type 1

CDC on Hyper-IgM syndrome type 1

Books

Books on Hyper-IgM syndrome type 1

News

Hyper-IgM syndrome type 1 in the news

Be alerted to news on Hyper-IgM syndrome type 1

News trends on Hyper-IgM syndrome type 1

Commentary

Blogs on Hyper-IgM syndrome type 1

Definitions

Definitions of Hyper-IgM syndrome type 1

Patient Resources / Community

Patient resources on Hyper-IgM syndrome type 1

Discussion groups on Hyper-IgM syndrome type 1

Patient Handouts on Hyper-IgM syndrome type 1

Directions to Hospitals Treating Hyper-IgM syndrome type 1

Risk calculators and risk factors for Hyper-IgM syndrome type 1

Healthcare Provider Resources

Symptoms of Hyper-IgM syndrome type 1

Causes & Risk Factors for Hyper-IgM syndrome type 1

Diagnostic studies for Hyper-IgM syndrome type 1

Treatment of Hyper-IgM syndrome type 1

Continuing Medical Education (CME)

CME Programs on Hyper-IgM syndrome type 1

International

Hyper-IgM syndrome type 1 en Espanol

Hyper-IgM syndrome type 1 en Francais

Business

Hyper-IgM syndrome type 1 in the Marketplace

Patents on Hyper-IgM syndrome type 1

Experimental / Informatics

List of terms related to Hyper-IgM syndrome type 1


Hyper IgM Syndrome Type 1 is the X-linked variant of the Hyper-IgM syndrome. The affected individuals are virtually always male, because males only have one X chromosome, received from their mothers. Their mothers are not symptomatic, even though they are carriers of the allele, because the trait is recessive. Male offspring of these women have a 50% chance of inheriting their mother's mutant allele.

Pathogenesis

This variant of the hyper-IgM syndrome is caused by mutation of the CD40LG gene. The genetic locus for this gene is Xq26. This gene codes for the CD40 ligand, which is expressed on T cells. When the CD40 ligand binds CD40 on B cells, then the B cell switches from producing IgM to producing IgA or IgG.

In these patients a biopsy of a ganglion may show poor development of structural and germinal centers because of the lack of activation of B cells by the T cells in them.

Signs & Symptoms

A patient presenting with Hyper IgM syndrome may be affected by simple infectious organisms in exposed regions like the respiratory system. Vaccination against pathogenic organisms may not help these individuals, because vaccinating them does not properly stimulate production of antibodies. Symptoms can include:

  • Fever (recurrent infections)
  • Low counts of IgA, IgG and IgE antibodies
  • CD40L not reactive in T cells

Treatment

Patients presenting with this disease undergo antibiotic treatment and gammaglobulin transfusions. Antibiotics are used to fight off the pathogenic organisms, and the gammaglobulin helps provide a normal balance of antibodies to fight the infection.

OMIM: 308230




Linked-in.jpg